NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AND OFFER OF THE SECURITIES DESCRIBED HEREIN
TORONTO, March 13, 2019 (GLOBE NEWSWIRE) -- A-Labs Capital II Corp. (TSXV: ALAB.P) (the “Company”) is issuing this press release to clarify certain information contained in its previously disseminated March 13, 2019 press release announcing the closing of the initial public offering (the “Press Release”). The Press Release referenced an incorrect stock symbol, TSXV: LABS, which may have caused confusion with MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ), a specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation company, currently trading on the TSX Venture Exchange under the stock symbol “LABS”, headquartered in Barrie, Ontario. The Company’s stock symbol is “ALAB.P”.
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FOR FURTHER INFORMATION PLEASE CONTACT:
Doron Cohen
Chief Executive Officer
Telephone: (972) 545-224-017
E-mail: doron@alabs.co